JASWINDER SINGH: Open Payments
NPI 1831416262 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,543 in 36 payments from 15 companies in 2025. Trend: 2023 $491 · 2024 $888 · 2025 $2,543
Food & beverage: $1,520Travel & lodging: $830Education: $193
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $1,193 |
| Teva Pharmaceuticals USA, Inc. | 5 | $466 |
| EMD Serono, Inc. | 2 | $149 |
| UCB, Inc. | 1 | $136 |
| TG Therapeutics, Inc. | 1 | $127 |
| Celgene Corporation | 1 | $88 |
| JAZZ PHARMACEUTICALS INC. | 1 | $77 |
| Biogen, Inc. | 3 | $66 |
| ACADIA Pharmaceuticals Inc | 1 | $57 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
Products named: Vercise, AUSTEDO XR, General - DBS, BRIUMVI, Mavenclad, ZEPOSIA, EPIDIOLEX, DAYBUE.
Industry payments across TX — which companies pay providers there.
